Skip to content

Circles

X

Xenetic Biosciences, Inc.

XBIO· Nasdaq

X

XBIOXenetic Biosciences, Inc.

XBIOXenetic Biosciences, Inc.·Earnings record

Q3 2013

Source filing unavailable

Previous · Q2 2013 Next · Q4 2013

Q3 2013 · —

Revenue—

Net Income

-$2.73M

no prior Q3 2012 on file

EPS Diluted

-$0.02

no prior Q3 2012 on file

Operating Income-$2,529,974—

Operating Cash Flowderived-$2,258,844—

Free Cash Flowderived

Same quarter

no prior Q3 2012 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q1 ’13 Q2 ’13Q3 ’13Q4 ’13^d Q1 ’14 Q2 ’14 Q3 ’14 Q4 ’14^d Q1 ’15…

Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR

-$2,263,819

—

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Movers Indexes IPOs Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Changelog Circles Account Terms Privacy